visilizumab


visilizumab
A humanized monoclonal antibody being investigated for use as an immunosuppressive drug in patients with ulcerative colitis and Crohns disease.

Wikipedia foundation.

Look at other dictionaries:

  • Visilizumab — ? Monoclonal antibody Type Whole antibody Source Humanized (from mouse) Target CD3 receptor Clinical data Pregnancy cat.  ? Legal status …   Wikipedia

  • visilizumab — A monoclonal antibody that binds to CD3 (a substance found on T cells) and that is being studied as a treatment for graft versus host disease (GVHD). It belongs to the family of drugs called monoclonal antibodies …   English dictionary of cancer terms

  • Daclizumab — ? Monoclonal antibody Type Whole antibody Source Humanized (from mouse) Target CD25 Clinical data Trade names Zenapax AHFS/Drugs.com …   Wikipedia

  • Omalizumab — ? Monoclonal antibody Type Whole antibody Source Humanized (from mouse) Target IgE Fc region …   Wikipedia

  • Natalizumab — ? Monoclonal antibody Type Whole antibody Source Humanized (from mouse) Target alpha 4 integrin Clinical data Trade names Tysabri AHFS/ …   Wikipedia

  • Metelimumab — ? Monoclonal antibody Type Whole antibody Source Human Target TGF beta 1 Clinical data Pregnancy cat.  ? Legal status …   Wikipedia

  • Odulimomab — ? Monoclonal antibody Type Whole antibody Source Mouse Target CD11a Clinical data Pregnancy cat.  ? Legal status …   Wikipedia

  • Maslimomab — ? Monoclonal antibody Source Mouse Target T cell receptor Clinical data Pregnancy cat.  ? Legal status  ? …   Wikipedia

  • Mepolizumab — ? Monoclonal antibody Type Whole antibody Source Humanized (from mouse) Target IL 5 Clinical data Pregnancy cat.  ? Legal status …   Wikipedia

  • Nerelimomab — ? Monoclonal antibody Type Whole antibody Source Mouse Target TNF alpha Clinical data Pregnancy cat.  ? Legal status  ? …   Wikipedia


Share the article and excerpts

Direct link
Do a right-click on the link above
and select “Copy Link”

We are using cookies for the best presentation of our site. Continuing to use this site, you agree with this.